Abbott closes 3 clinical trials for disappearing drug-eluting coronary stent | bioprocessing process development | Scoop.it
Healthcare giant Abbott completes enrollment in 3 clinical trials evaluating its novel dissolving, drug-eluting scaffold in patients with blocked heart vessels.

Via Beeyond